Institut De Recherches Internationales Servier (i.r.i.s.)

This early-stage study aims to understand if taking the cancer drug vorasidenib changes how the body processes a common birth control pill. Researchers will enroll 28 healthy adult women to measure drug levels in the blood and check for side effects. The goal is to gather safety …